J9352 HCPCS code: Injection, trabectedin, 0.1 mg
J9352 is the HCPCS Level II code for injection, trabectedin, 0.1 mg. CMS terminated J9352 on 2026-09-30; do not bill it for later dates of service. In 2024 Medicare paid an average of $270.93 per service for J9352 across 14,565 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 40 per day on outpatient hospital claims. Medicare volume rose 17% from 2022 to 2024 (12,483 to 14,565 services). In 2024, about 203 clinicians billed Medicare for J9352 for 137 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2017-01-01 |
| Last action effective | 2026-10-01 |
| Terminated | 2026-09-30 |
Who bills J9352 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 203 |
| Medicare beneficiaries | 137 |
| States with claims | 4 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9352, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 12,483 | 107 | $321.78 | $256.99 |
| 2023 | 13,377 | 122 | $327.83 | $261.19 |
| 2024 | 14,565 | 137 | $340.09 | $270.93 |
States with the most J9352 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 3,696 | $268.42 |
| Texas | 1,890 | $271.18 |
| Florida | 990 | $269.40 |
| Missouri | 850 | $267.03 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 40 | Prescribing Information |
| practitioner claims | 40 | Prescribing Information |
What changed for J9352
- 2026-10-01: Last CMS action: code discontinued
- 2017-01-01: J9352 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9352?
J9352 is the HCPCS Level II code for injection, trabectedin, 0.1 mg. Short descriptor: "Injection trabectedin 0.1mg".
How much does Medicare pay for J9352?
In 2024, the average Medicare payment was $270.93 per service (average allowed $340.09).
Does Medicare cover J9352?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9352 can be billed per day?
40 on outpatient hospital claims; 40 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9352
- Watch J9352 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9352
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.